In particular, we found ANA profile positivity in 9/19 pts (47.3%) while 3/19 (15.8%) MDS patients displayed ENA screen positivity and 2/19 (10.5%) dsDNA positivity, Supplementary Fig. 2. The gene discussed is BTG3; the disease is myelodysplastic syndrome.